Skip to main content
    T

    Tenon Medical Inc (TNON)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $1.33
    -0.07 (-5.32%)

    Market Cap: $3.79M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Tenon Medical Inc (TNON) Financials: Revenue, Profit and Cash Flow

    Updated Nov 12, 2026. Financial statements from company filings, amounts in US dollars.

    Tenon Medical reported revenue of $3.94M for the fiscal year ended Dec 31, 2025, up 20.4% from the year before. That year, net income was -$12.56M with a net margin of -318.4%, operating cash flow was -$10.74M and free cash flow was -$11.02M. The quarter ended Sep 30, 2026 had revenue of $1.43M and net income of -$6.64M.

    Revenue and Margins

    Over the 6 years to Dec 2025, revenue grew from $53.64K, a compound annual rate of 104.6%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$3.94M+20.4%59.8%-324.3%-318.4%
    Dec 2024$3.28M+11.9%52.2%-420.1%-417.2%
    Dec 2023$2.93M+323.7%42.4%-537.1%-532.1%
    Dec 2022$691.00K+331.9%-92.8%-2709.8%-2737.6%
    Dec 2021$160.00K+265.1%65.6%-4038.1%-4425.6%
    Dec 2020$43.82K-18.3%58.3%-1223.8%-1335.4%
    Dec 2019$53.64KN/A66.0%-994.5%-950.0%
    Annual, fiscal years ended Dec 2019 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Revenue$3.94M$3.28M$2.93M$691.00K$160.00K$43.82K$53.64K
    Cost of revenue$1.59M$1.57M$1.69M$1.33M$55.00K$18.26K$18.26K
    Gross profit$2.36M$1.71M$1.24M-$641.00K$105.00K$25.56K$35.38K
    Research and development$2.15M$2.60M$3.16M$2.83M$1.72M$220.88K$371.55K
    Operating income-$12.79M-$13.77M-$15.73M-$18.73M-$6.46M-$536.29K-$533.44K
    Net income-$12.56M-$13.67M-$15.58M-$18.92M-$7.08M-$585.18K-$509.58K
    EBITDA-$12.26M-$13.17M-$15.30M-$18.45M-$6.35MN/A-$30
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$1.43M$1.28M$1.38M$1.48M$1.17M$564.00K$726.00K$770.00K$887.00K$901.00K$719.00K$808.00K
    Gross profit$950.00K$814.00K$945.00K$1.02M$773.00K$245.00K$323.00K$353.00K$418.00K$470.00K$470.00K$559.00K
    Operating income-$3.08M-$3.35M-$3.28M-$2.87M-$3.39M-$2.86M-$3.68M-$3.17M-$3.21M-$3.87M-$3.51M-$3.14M
    Net income-$6.64M-$4.05M-$3.48M-$2.83M-$3.34M-$2.77M-$3.62M-$3.09M-$3.18M-$3.83M-$3.58M-$3.13M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $0 by $3.76M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Total assets$10.76M$9.84M$6.34M$11.09M$9.27M$390.90K$268.45K
    Current assets$6.77M$8.21M$3.89M$9.35M$7.67M$303.40K$268.45K
    Cash and equivalents$3.76M$6.54M$2.43M$2.13M$2.92M$245.63K$151.97K
    Total liabilities$5.72M$3.87M$5.57M$4.84M$16.18M$1.83M$1.88M
    Short-term debt$0$287.00K$1.17M$0$12.86M$241.40K$734.41K
    Long-term debtN/AN/AN/AN/AN/A$333.58KN/A
    Shareholder equity$5.04M$5.97M$778.00K$6.25M-$20.55M-$3.14M-$2.61M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$16.20M$9.92M$12.84M$10.76M$10.37M$11.11M$13.39M$9.84M$13.04M$6.01M$8.02M$6.34M
    Total liabilities$6.98M$11.66M$10.94M$5.72M$5.57M$4.40M$4.02M$3.87M$4.85M$5.17M$4.40M$5.57M
    Cash and equivalents$8.27M$1.68M$4.61M$3.76M$3.44M$7.85M$10.31M$6.54M$9.16M$1.97M$4.39M$2.43M
    Shareholder equity$9.22M-$1.74M$1.90M$5.04M$4.80M$6.71M$9.38M$5.97M$8.19M$832.00K$3.62M$778.00K
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Operating cash flow-$10.74M-$9.88M-$12.18M-$12.03M-$4.29M-$167.36K-$235.20K
    Capital expenditures$273.00K$186.00K$361.00K$847.00K$102.00K$3$102.00K
    Free cash flow-$11.02M-$10.06M-$12.54M-$12.87M-$4.39M-$167.37K-$337.20K
    Share repurchases$928.00K$1.10MN/AN/AN/AN/AN/A
    Investing cash flow-$1.02M-$186.00K$6.14M-$2.88M-$4.50M-$4.50M$64.49K
    Financing cash flow$8.99M$14.13M$6.30M$14.11M$11.47M$254.80K$321.31K
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$2.39M-$2.76M-$2.96M-$2.22M-$3.82M-$2.21M-$2.48M-$2.78M-$2.34M-$2.42M-$2.34M-$2.28M
    Capital expenditures$8.00K$172.00K$56.00K$192.00K$111.00K$192.00K$0$37.00K$104.00K$0$119.00K$92.00K
    Free cash flow-$2.40M-$2.93M-$3.02M-$2.42M-$3.94M-$2.41M-$2.48M-$2.81M-$2.45M-$2.42M-$2.46M-$2.37M
    Last 12 quarters

    Frequently Asked Questions About TNON

    What is Tenon Medical's annual revenue?

    Tenon Medical reported revenue of $3.94M for the fiscal year ended Dec 31, 2025.

    How fast is Tenon Medical's revenue growing?

    Revenue was up 20.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 78.7%.

    Is Tenon Medical profitable?

    No. Tenon Medical reported net income of -$12.56M for the fiscal year ended Dec 31, 2025, with a net margin of -318.4%.

    How much free cash flow does TNON generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$10.74M minus capital expenditures of $273.00K produced free cash flow of -$11.02M.

    How much debt does Tenon Medical have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $0 and cash and equivalents of $3.76M.